The angiopoietin-Tie2 signaling axis in the vascular leakage of systemic inflammation

References

• Partanen J, Armstrong E, Makela TP, Korhonen J, Sandberg M, Renkonen R, Knuutila S, Huebner K, Alitalo K. A novel endothelial cell surface receptor tyrosine kinase with extracellular epidermal growth factor homology domains. Mol Cell Biol 1992; 12:1698-707; PMID:1312667
   PubMed Web of Science ®Google Scholar
• Dumont DJ, Yamaguchi TP, Conlon RA, Rossant J, Breitman ML. Tek, a novel tyrosine kinase gene located on mouse chromosome 4, is expressed in endothelial cells and their presumptive precursors. Oncogene 1992; 7:1471-80; PMID:1630810
   PubMed Web of Science ®Google Scholar
• Dumont DJ, Gradwohl G, Fong GH, Puri MC, Gertsenstein M, Auerbach A, Breitman ML. Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo. Genes Dev 1994; 8:1897-909; PMID:7958865; http://dx.doi.org/10.1101/gad.8.16.1897
   PubMed Web of Science ®Google Scholar
• Maisonpierre PC, Suri C, Jones PF, Bartunkova S, Wiegand SJ, Radziejewski C, Compton D, McClain J, Aldrich TH, Papadopoulos N, et al. Angiopoietin-2, a natural antagonist for tie2 that disrupts in vivo angiogenesis. Science 1997; 277:55-60; PMID:9204896; http://dx.doi.org/10.1126/science.277.5322.55
   PubMed Web of Science ®Google Scholar
• Suri C, Jones PF, Patan S, Bartunkova S, Maisonpierre PC, Davis S, Sato TN, Yancopoulos GD. Requisite role of angiopoietin-1, a ligand for the tie2 receptor, during embryonic angiogenesis. Cell 1996; 87:1171-80; PMID:8980224; http://dx.doi.org/10.1016/S0092-8674(00)81813-9
   PubMed Web of Science ®Google Scholar
• Yuan HT, Venkatesha S, Chan B, Deutsch U, Mammoto T, Sukhatme VP, Woolf AS, Karumanchi SA. Activation of the orphan endothelial receptor tie1 modifies tie2-mediated intracellular signaling and cell survival. FASEB J 2007; 21:3171-83; PMID:17504972; http://dx.doi.org/10.1096/fj.07-8487com
   PubMed Web of Science ®Google Scholar
• Seegar TC, Eller B, Tzvetkova-Robev D, Kolev MV, Henderson SC, Nikolov DB, Barton WA. Tie1-tie2 interactions mediate functional differences between angiopoietin ligands. Mol Cell 2010; 37:643-55; PMID:20227369; http://dx.doi.org/10.1016/j.molcel.2010.02.007
   PubMed Web of Science ®Google Scholar
• Jeltsch M, Leppanen VM, Saharinen P, Alitalo K. Receptor tyrosine kinase-mediated angiogenesis. Cold Spring Harb Perspect Biol 2013; 5(9); PMID:24003209;
   PubMedGoogle Scholar
• Jones N, Dumont DJ. The tek/tie2 receptor signals through a novel dok-related docking protein, dok-r. Oncogene 1998; 17:1097-108; PMID:9764820; http://dx.doi.org/10.1038/sj.onc.1202115
   PubMed Web of Science ®Google Scholar
• Harfouche R, Hassessian HM, Guo Y, Faivre V, Srikant CB, Yancopoulos GD, Hussain SN. Mechanisms which mediate the antiapoptotic effects of angiopoietin-1 on endothelial cells. Microvasc Res. 2002; 64:135-147; PMID:12074640; http://dx.doi.org/10.1006/mvre.2002.2421
   PubMed Web of Science ®Google Scholar
• Li X, Stankovic M, Bonder CS, Hahn CN, Parsons M, Pitson SM, Xia P, Proia RL, Vadas MA, Gamble JR. Basal and angiopoietin-1-mediated endothelial permeability is regulated by sphingosine kinase-1. Blood. 2008; 111:3489-97; PMID:18199826; http://dx.doi.org/10.1182/blood-2007-05-092148
   PubMed Web of Science ®Google Scholar
• Mammoto T, Parikh SM, Mammoto A, Gallagher D, Chan B, Mostoslavsky G, Ingber DE, Sukhatme VP. Angiopoietin-1 requires p190 rhogap to protect against vascular leakage in vivo. J Biol Chem. 2007; 282:23910-8; PMID:17562701; http://dx.doi.org/10.1074/jbc.M702169200
   PubMed Web of Science ®Google Scholar
• Ghosh CC, Mukherjee A, David S, Knaus UG, Stearns-Kurosawa DJ, Kurosawa S, Parikh SM. Impaired function of the tie-2 receptor contributes to vascular leakage and lethality in anthrax. Proc Natl Acad Sci U S A. 2012; 109:10024-9; PMID:22665799; http://dx.doi.org/10.1073/pnas.1120755109
   PubMed Web of Science ®Google Scholar
• Yuan HT, Khankin EV, Karumanchi SA, Parikh SM. Angiopoietin 2 is a partial agonist/antagonist of tie2 signaling in the endothelium. Mol Cell Biol 2009; 29:2011-22; PMID:19223473; http://dx.doi.org/10.1128/MCB.01472-08
   PubMed Web of Science ®Google Scholar
• Bogdanovic E, Nguyen VP, Dumont DJ. Activation of tie2 by angiopoietin-1 and angiopoietin-2 results in their release and receptor internalization. J Cell Sci 2006; 119:3551-60; PMID:16895971; http://dx.doi.org/10.1242/jcs.03077
   PubMedGoogle Scholar
• Cascone I, Napione L, Maniero F, Serini G, Bussolino F. Stable interaction between alpha5beta1 integrin and tie2 tyrosine kinase receptor regulates endothelial cell response to ang-1. J Cell Biol 2005; 170:993-1004; PMID:16157706; http://dx.doi.org/10.1083/jcb.200507082
   PubMed Web of Science ®Google Scholar
• Felcht M, Luck R, Schering A, Seidel P, Srivastava K, Hu J, Bartol A, Kienast Y, Vettel C, Loos EK, et al. Angiopoietin-2 differentially regulates angiogenesis through tie2 and integrin signaling. J Clin Invest 2012; 122:1991-2005; PMID:22585576; http://dx.doi.org/10.1172/JCI58832
   PubMed Web of Science ®Google Scholar
• Gale NW, Thurston G, Hackett SF, Renard R, Wang Q, McClain J, Martin C, Witte C, Witte MH, Jackson D, et al. Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by angiopoietin-1. Dev Cell 2002; 3:411-23; PMID:12361603; http://dx.doi.org/10.1016/S1534-5807(02)00217-4
   PubMed Web of Science ®Google Scholar
• Wong AL, Haroon ZA, Werner S, Dewhirst MW, Greenberg CS, Peters KG. Tie2 expression and phosphorylation in angiogenic and quiescent adult tissues. Circ Res 1997; 81:567-74; PMID:9314838; http://dx.doi.org/10.1161/01.RES.81.4.567
   PubMed Web of Science ®Google Scholar
• Thurston G, Rudge JS, Ioffe E, Zhou H, Ross L, Croll SD, Glazer N, Holash J, McDonald DM, Yancopoulos GD. Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat Med 2000; 6:460-3; PMID:10742156; http://dx.doi.org/10.1038/74725
   PubMed Web of Science ®Google Scholar
• Thurston G, Suri C, Smith K, McClain J, Sato TN, Yancopoulos GD, McDonald DM. Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science 1999; 286:2511-4; PMID:10617467; http://dx.doi.org/10.1126/science.286.5449.2511
   PubMed Web of Science ®Google Scholar
• Parikh SM, Mammoto T, Schultz A, Yuan HT, Christiani D, Karumanchi SA, Sukhatme VP. Excess circulating angiopoietin-2 may contribute to pulmonary vascular leak in sepsis in humans. PLoS Med 2006; 3:e46; PMID:16417407; http://dx.doi.org/10.1371/journal.pmed.0030046
   PubMedGoogle Scholar
• Bhandari V, Choo-Wing R, Lee CG, Zhu Z, Nedrelow JH, Chupp GL, Zhang X, Matthay MA, Ware LB, Homer RJ, et al. Hyperoxia causes angiopoietin 2-mediated acute lung injury and necrotic cell death. Nat Med 2006; 12:1286-93; PMID:17086189; http://dx.doi.org/10.1038/nm1494
   PubMed Web of Science ®Google Scholar
• Fiedler U, Reiss Y, Scharpfenecker M, Grunow V, Koidl S, Thurston G, Gale NW, Witzenrath M, Rosseau S, Suttorp N, et al. Angiopoietin-2 sensitizes endothelial cells to tnf-alpha and has a crucial role in the induction of inflammation. Nat Med 2006; 12:235-9; PMID:16462802; http://dx.doi.org/10.1038/nm1351
   PubMed Web of Science ®Google Scholar
• Parikh SM. Dysregulation of the angiopoietin-tie-2 axis in sepsis and ards. Virulence 2013; 4:517-24; PMID:23652985; http://dx.doi.org/10.4161/viru.24906
   PubMed Web of Science ®Google Scholar
• Trejo J, Altschuler Y, Fu HW, Mostov KE, Coughlin SR. Protease-activated receptor-1 down-regulation: A mutant hela cell line suggests novel requirements for par1 phosphorylation and recruitment to clathrin-coated pits. J Biol Chem 2000; 275:31255-65; PMID:10893235; http://dx.doi.org/10.1074/jbc.M003770200
   PubMed Web of Science ®Google Scholar
• Serhan CN. Pro-resolving lipid mediators are leads for resolution physiology. Nature 2014; 510:92-101; PMID:24899309; http://dx.doi.org/10.1038/nature13479
   PubMed Web of Science ®Google Scholar
• Springer TA, Thompson WS, Miller LJ, Schmalstieg FC, Anderson DC. Inherited deficiency of the mac-1, lfa-1, p150,95 glycoprotein family and its molecular basis. J Exp Med 1984; 160:1901-18; PMID:6096477; http://dx.doi.org/10.1084/jem.160.6.1901
   PubMed Web of Science ®Google Scholar
• Malinin NL, Zhang L, Choi J, Ciocea A, Razorenova O, Ma YQ, Podrez EA, Tosi M, Lennon DP, Caplan AI, et al. A point mutation in kindlin3 ablates activation of three integrin subfamilies in humans. Nat Med 2009; 15:313-8; PMID:19234460; http://dx.doi.org/10.1038/nm.1917
   PubMed Web of Science ®Google Scholar
• Majno G, Palade GE, Schoefl GI. Studies on inflammation. Ii. The site of action of histamine and serotonin along the vascular tree: A topographic study. J Biophys Biochem Cytol 1961; 11:607-26; PMID:14468625; http://dx.doi.org/10.1083/jcb.11.3.607
   PubMedGoogle Scholar
• Majno G, Palade GE. Studies on inflammation. 1. The effect of histamine and serotonin on vascular permeability: An electron microscopic study. J Biophys Biochem Cytol 1961; 11:571-605; PMID:14468626; http://dx.doi.org/10.1083/jcb.11.3.571
   PubMedGoogle Scholar
• Vandenbroucke E, Mehta D, Minshall R, Malik AB. Regulation of endothelial junctional permeability. Ann N Y Acad Sci 2008; 1123:134-45; PMID:18375586; http://dx.doi.org/10.1196/annals.1420.016
   PubMed Web of Science ®Google Scholar
• Dejana E, Orsenigo F, Molendini C, Baluk P, McDonald DM. Organization and signaling of endothelial cell-to-cell junctions in various regions of the blood and lymphatic vascular trees. Cell Tissue Res 2009; 335:17-25; PMID:18855014; http://dx.doi.org/10.1007/s00441-008-0694-5
   PubMed Web of Science ®Google Scholar
• Corada M, Mariotti M, Thurston G, Smith K, Kunkel R, Brockhaus M, Lampugnani MG, Martin-Padura I, Stoppacciaro A, Ruco L, et al. Vascular endothelial-cadherin is an important determinant of microvascular integrity in vivo. Proc Natl Acad Sci U S A 1999; 96:9815-20; PMID:10449777; http://dx.doi.org/10.1073/pnas.96.17.9815
   PubMed Web of Science ®Google Scholar
• Yano K, Liaw PC, Mullington JM, Shih SC, Okada H, Bodyak N, Kang PM, Toltl L, Belikoff B, Buras J, et al. Vascular endothelial growth factor is an important determinant of sepsis morbidity and mortality. J Exp Med 2006; 203:1447-58; PMID:16702604; http://dx.doi.org/10.1084/jem.20060375
   PubMed Web of Science ®Google Scholar
• London NR, Zhu W, Bozza FA, Smith MC, Greif DM, Sorensen LK, Chen L, Kaminoh Y, Chan AC, Passi SF, et al. Targeting robo4-dependent slit signaling to survive the cytokine storm in sepsis and influenza. Sci Transl Med 2010; 2:23ra19; PMID:20375003
   PubMed Web of Science ®Google Scholar
• Puneet P, Yap CT, Wong L, Lam Y, Koh DR, Moochhala S, Pfeilschifter J, Huwiler A, Melendez AJ. Sphk1 regulates proinflammatory responses associated with endotoxin and polymicrobial sepsis. Science 2010; 328:1290-4; PMID:20522778; http://dx.doi.org/10.1126/science.1188635
   PubMed Web of Science ®Google Scholar
• Sanchez T, Estrada-Hernandez T, Paik JH, Wu MT, Venkataraman K, Brinkmann V, Claffey K, Hla T. Phosphorylation and action of the immunomodulator fty720 inhibits vascular endothelial cell growth factor-induced vascular permeability. J Biol Chem 2003; 278:47281-90; PMID:12954648; http://dx.doi.org/10.1074/jbc.M306896200
   PubMed Web of Science ®Google Scholar
• Witzenbichler B, Westermann D, Knueppel S, Schultheiss HP, Tschope C. Protective role of angiopoietin-1 in endotoxic shock. Circulation 2005; 111:97-105; PMID:15611372; http://dx.doi.org/10.1161/01.CIR.0000151287.08202.8E
   PubMed Web of Science ®Google Scholar
• David S, Ghosh CC, Mukherjee A, Parikh SM. Angiopoietin-1 requires iq domain gtpase-activating protein 1 to activate rac1 and promote endothelial barrier defense. Arterioscler Thromb Vasc Biol 2011; 31:2643-52; PMID:21885850; http://dx.doi.org/10.1161/ATVBAHA.111.233189
   PubMed Web of Science ®Google Scholar
• Dallabrida SM, Ismail N, Oberle JR, Himes BE, Rupnick MA. Angiopoietin-1 promotes cardiac and skeletal myocyte survival through integrins. Circ Res 2005; 96:e8-24; PMID:15692086; http://dx.doi.org/10.1161/01.RES.0000158285.57191.60
   PubMedGoogle Scholar
• Xu Y, Yu Q. Angiopoietin-1, unlike angiopoietin-2, is incorporated into the extracellular matrix via its linker peptide region. J Biol Chem 2001; 276:34990-8; PMID:11447223; http://dx.doi.org/10.1074/jbc.M103661200
   PubMed Web of Science ®Google Scholar
• Lampugnani MG, Resnati M, Dejana E, Marchisio PC. The role of integrins in the maintenance of endothelial monolayer integrity. J Cell Biol 1991; 112:479-90; PMID:1899416; http://dx.doi.org/10.1083/jcb.112.3.479
   PubMed Web of Science ®Google Scholar
• Tournaire R, Simon MP, le Noble F, Eichmann A, England P, Pouyssegur J. A short synthetic peptide inhibits signal transduction, migration and angiogenesis mediated by tie2 receptor. EMBO reports 2004; 5:262-7; PMID:14978510; http://dx.doi.org/10.1038/sj.embor.7400100
   PubMedGoogle Scholar
• David S, Ghosh CC, Kumpers P, Shushakova N, Van Slyke P, Khankin EV, Karumanchi SA, Dumont D, Parikh SM. Effects of a synthetic peg-ylated tie-2 agonist peptide on endotoxemic lung injury and mortality. Am J Physiol Lung Cell Mol Physiol 2011; 300:L851-62; PMID:21421750; http://dx.doi.org/10.1152/ajplung.00459.2010
   PubMedGoogle Scholar
• Kumpers P, Gueler F, David S, Van Slyke P, Dumont DJ, Park JK, Bockmeyer CL, Parikh SM, Pavenstadt H, Haller H, et al. The synthetic tie2 agonist peptide vasculotide protects against vascular leakage and reduces mortality in murine abdominal sepsis. Crit Care 2011; 15:R261; PMID:22040774; http://dx.doi.org/10.1186/cc10523
   PubMed Web of Science ®Google Scholar
• Jeansson M, Gawlik A, Anderson G, Li C, Kerjaschki D, Henkelman M, Quaggin SE. Angiopoietin-1 is essential in mouse vasculature during development and in response to injury. J Clin Invest 2011; 121:2278-89; PMID:21606590; http://dx.doi.org/10.1172/JCI46322
   PubMed Web of Science ®Google Scholar
• Saharinen P, Eklund L, Miettinen J, Wirkkala R, Anisimov A, Winderlich M, Nottebaum A, Vestweber D, Deutsch U, Koh GY, et al. Angiopoietins assemble distinct tie2 signalling complexes in endothelial cell-cell and cell-matrix contacts. Nat Cell Biol 2008; 10:527-37; PMID:18425119; http://dx.doi.org/10.1038/ncb1715
   PubMed Web of Science ®Google Scholar
• Fukuhara S, Sako K, Minami T, Noda K, Kim HZ, Kodama T, Shibuya M, Takakura N, Koh GY, Mochizuki N. Differential function of tie2 at cell-cell contacts and cell-substratum contacts regulated by angiopoietin-1. Nat Cell Biol 2008; 10:513-26; PMID:18425120; http://dx.doi.org/10.1038/ncb1714
   PubMed Web of Science ®Google Scholar
• Aslan A, Jongman RM, Moser J, Stegeman CA, van Goor H, Diepstra A, van den Heuvel MC, Heeringa P, Molema G, Zijlstra JG, et al. The renal angiopoietin/tie2 system in lethal human sepsis. Crit Care 2014; 18:423; PMID:24976393; http://dx.doi.org/10.1186/cc13806
   PubMedGoogle Scholar
• David S, Mukherjee A, Ghosh CC, Yano M, Khankin EV, Wenger JB, Karumanchi SA, Shapiro NI, Parikh SM. Angiopoietin-2 may contribute to multiple organ dysfunction and death in sepsis. Crit Care Med 2012; 40:3034-41; PMID:22890252; http://dx.doi.org/10.1097/CCM.0b013e31825fdc31
   PubMed Web of Science ®Google Scholar
• Fiedler U, Scharpfenecker M, Koidl S, Hegen A, Grunow V, Schmidt JM, Kriz W, Thurston G, Augustin HG. The tie-2 ligand angiopoietin-2 is stored in and rapidly released upon stimulation from endothelial cell weibel-palade bodies. Blood 2004; 103:4150-6; PMID:14976056; http://dx.doi.org/10.1182/blood-2003-10-3685
   PubMed Web of Science ®Google Scholar
• Stiehl T, Thamm K, Kaufmann J, Schaeper U, Kirsch T, Haller H, Santel A, Ghosh CC, Parikh SM, David S. Lung-targeted rna-interference against angiopoietin-2 ameliorates multi-organ dusfunction and death in sepsis. Crit Care Med 2014; (accepted); PMID:25083983
   PubMedGoogle Scholar
• Daly C, Wong V, Burova E, Wei Y, Zabski S, Griffiths J, Lai KM, Lin HC, Ioffe E, Yancopoulos GD, et al. Angiopoietin-1 modulates endothelial cell function and gene expression via the transcription factor fkhr (foxo1). Genes Dev 2004; 18:1060-71; PMID:15132996; http://dx.doi.org/10.1101/gad.1189704
   PubMed Web of Science ®Google Scholar
• David S, Kumpers P, van Slyke P, Parikh SM. Mending leaky blood vessels: The angiopoietin-tie2 pathway in sepsis. J Pharmacol Exp Ther 2013; 345:2-6; PMID:23378191; http://dx.doi.org/10.1124/jpet.112.201061
   PubMed Web of Science ®Google Scholar
• van der Heijden M, Pickkers P, van Nieuw Amerongen GP, van Hinsbergh VW, Bouw MP, van der Hoeven JG, Groeneveld AB. Circulating angiopoietin-2 levels in the course of septic shock: Relation with fluid balance, pulmonary dysfunction and mortality. Intensive Care Med 2009; 35:1567-74; PMID:19551369; http://dx.doi.org/10.1007/s00134-009-1560-y
   PubMed Web of Science ®Google Scholar
• van der Heijden M, van Nieuw Amerongen GP, Koolwijk P, van Hinsbergh VW, Groeneveld AB. Angiopoietin-2, permeability oedema, occurrence and severity of ali/ards in septic and non-septic critically ill patients. Thorax 2008; 63:903-9; PMID:18559364; http://dx.doi.org/10.1136/thx.2007.087387
   PubMed Web of Science ®Google Scholar
• Meyer NJ, Li M, Feng R, Bradfield J, Gallop R, Bellamy S, Fuchs BD, Lanken PN, Albelda SM, Rushefski M, et al. Angpt2 genetic variant is associated with trauma-associated acute lung injury and altered plasma angiopoietin-2 isoform ratio. Am J Respir Crit Care Med 2011; 183:1344-53; PMID:21257790; http://dx.doi.org/10.1164/rccm.201005-0701OC
   PubMed Web of Science ®Google Scholar
• Kim KT, Choi HH, Steinmetz MO, Maco B, Kammerer RA, Ahn SY, Kim HZ, Lee GM, Koh GY. Oligomerization and multimerization are critical for angiopoietin-1 to bind and phosphorylate tie2. J Biol Chem 2005; 280:20126-31; PMID:15769741; http://dx.doi.org/10.1074/jbc.M500292200
   PubMed Web of Science ®Google Scholar
• Davis S, Papadopoulos N, Aldrich TH, Maisonpierre PC, Huang T, Kovac L, Xu A, Leidich R, Radziejewska E, Rafique A, et al. Angiopoietins have distinct modular domains essential for receptor binding, dimerization and superclustering. Nat Struct Biol 2003; 10:38-44; PMID:12469114; http://dx.doi.org/10.1038/nsb880
   PubMedGoogle Scholar
• Barton WA, Tzvetkova-Robev D, Miranda EP, Kolev MV, Rajashankar KR, Himanen JP, Nikolov DB. Crystal structures of the tie2 receptor ectodomain and the angiopoietin-2-tie2 complex. Nat Struc Mol Biol 2006; 13:524-32; PMID:16732286; http://dx.doi.org/10.1038/nsmb1101
   PubMed Web of Science ®Google Scholar
• Yu X, Seegar TC, Dalton AC, Tzvetkova-Robev D, Goldgur Y, Rajashankar KR, Nikolov DB, Barton WA. Structural basis for angiopoietin-1-mediated signaling initiation. Proc Natl Acad Sci U S A 2013; 110:7205-10; PMID:23592718; http://dx.doi.org/10.1073/pnas.1216890110
   PubMedGoogle Scholar
• Fuxe J, Tabruyn S, Colton K, Zaid H, Adams A, Baluk P, Lashnits E, Morisada T, Le T, O'Brien S, et al. Pericyte requirement for anti-leak action of angiopoietin-1 and vascular remodeling in sustained inflammation. Am J Pathol 2011; 178:2897-909; PMID:21550017; http://dx.doi.org/10.1016/j.ajpath.2011.02.008
   PubMed Web of Science ®Google Scholar
• Ziegler T, Horstkotte J, Schwab C, Pfetsch V, Weinmann K, Dietzel S, Rohwedder I, Hinkel R, Gross L, Lee S, et al. Angiopoietin 2 mediates microvascular and hemodynamic alterations in sepsis. J Clin Invest 2013; epub ahead of print; PMID:23863629
   PubMed Web of Science ®Google Scholar
• Woo KV, Qu X, Babaev VR, Linton MF, Guzman RJ, Fazio S, Baldwin HS. Tie1 attenuation reduces murine atherosclerosis in a dose-dependent and shear stress-specific manner. J Clin Invest 2011; 121:1624-35; PMID:21383501; http://dx.doi.org/10.1172/JCI42040
   PubMed Web of Science ®Google Scholar
• Korhonen J, Partanen J, Armstrong E, Vaahtokari A, Elenius K, Jalkanen M, Alitalo K. Enhanced expression of the tie receptor tyrosine kinase in endothelial cells during neovascularization. Blood 1992; 80:2548-55; PMID:1384789
   PubMed Web of Science ®Google Scholar
• Kaipainen A, Vlaykova T, Hatva E, Bohling T, Jekunen A, Pyrhonen S, Alitalo K. Enhanced expression of the tie receptor tyrosine kinase mesenger rna in the vascular endothelium of metastatic melanomas. Cancer Res 1994; 54:6571-7; PMID:7987857
   PubMed Web of Science ®Google Scholar
• Puri MC, Rossant J, Alitalo K, Bernstein A, Partanen J. The receptor tyrosine kinase tie is required for integrity and survival of vascular endothelial cells. EMBO J 1995; 14:5884-91; PMID:8846781
   PubMed Web of Science ®Google Scholar
• D'Amico G, Korhonen EA, Anisimov A, Zarkada G, Holopainen T, Hagerling R, Kiefer F, Eklund L, Sormunen R, Elamaa H, et al. Tie1 deletion inhibits tumor growth and improves angiopoietin antagonist therapy. J Clin Invest 2014; 124:824-34; PMID:24430181; http://dx.doi.org/10.1172/JCI68897
   PubMed Web of Science ®Google Scholar
• van Meurs M, Kurniati NF, Wulfert FM, Asgeirsdottir SA, de Graaf IA, Satchell SC, Mathieson PW, Jongman RM, Kumpers P, Zijlstra JG, et al. Shock-induced stress induces loss of microvascular endothelial tie2 in the kidney which is not associated with reduced glomerular barrier function. Am J Physiol Renal Physiol 2009; 297:F272-81; PMID:19515812; http://dx.doi.org/10.1152/ajprenal.00137.2009
   PubMedGoogle Scholar
• Suarez Y, Fernandez-Hernando C, Yu J, Gerber SA, Harrison KD, Pober JS, Iruela-Arispe ML, Merkenschlager M, Sessa WC. Dicer-dependent endothelial micrornas are necessary for postnatal angiogenesis. Proc Natl Acad Sci U S A 2008; 105:14082-7; PMID:18779589; http://dx.doi.org/10.1073/pnas.0804597105
   PubMed Web of Science ®Google Scholar
• Li R, Zijlstra JG, Kamps JA, van Meurs M, Molema G. Abrupt reflow enhances cytokine induced pro-inflammatory activation of endothelial cells during simulated shock and resuscitation. Shock 2014; PMID:25051282
   PubMed Web of Science ®Google Scholar
• Wehrle C, Van Slyke P, Dumont DJ. Angiopoietin-1-induced ubiquitylation of tie2 by c-cbl is required for internalization and degradation. Biochem J 2009; 423:375-80; PMID:19689429; http://dx.doi.org/10.1042/BJ20091010
   PubMedGoogle Scholar
• Fachinger G, Deutsch U, Risau W. Functional interaction of vascular endothelial-protein-tyrosine phosphatase with the angiopoietin receptor tie-2. Oncogene 1999; 18:5948-53; PMID:10557082; http://dx.doi.org/10.1038/sj.onc.1202992
   PubMed Web of Science ®Google Scholar
• Baumer S, Keller L, Holtmann A, Funke R, August B, Gamp A, Wolburg H, Wolburg-Buchholz K, Deutsch U, Vestweber D. Vascular endothelial cell-specific phosphotyrosine phosphatase (ve-ptp) activity is required for blood vessel development. Blood 2006; 107:4754-62; PMID:16514057; http://dx.doi.org/10.1182/blood-2006-01-0141
   PubMedGoogle Scholar
• Dominguez MG, Hughes VC, Pan L, Simmons M, Daly C, Anderson K, Noguera-Troise I, Murphy AJ, Valenzuela DM, Davis S, et al. Vascular endothelial tyrosine phosphatase (ve-ptp)-null mice undergo vasculogenesis but die embryonically because of defects in angiogenesis. Proc Natl Acad Sci U S A 2007; 104:3243-8; PMID:17360632; http://dx.doi.org/10.1073/pnas.0611510104
   PubMedGoogle Scholar
• Kuppers V, Vockel M, Nottebaum AF, Vestweber D. Phosphatases and kinases as regulators of the endothelial barrier function. Cell Tissue Res. 2014; 355:577-86; PMID:24566520; http://dx.doi.org/10.1007/s00441-014-1812-1
   PubMedGoogle Scholar
• Hayashi M, Majumdar A, Li X, Adler J, Sun Z, Vertuani S, Hellberg C, Mellberg S, Koch S, Dimberg A, et al. Ve-ptp regulates vegfr2 activity in stalk cells to establish endothelial cell polarity and lumen formation. Nat Commun 2013; 4:1672; PMID:23575676; http://dx.doi.org/10.1038/ncomms2683
   PubMed Web of Science ®Google Scholar
• Nawroth R, Poell G, Ranft A, Kloep S, Samulowitz U, Fachinger G, Golding M, Shima DT, Deutsch U, Vestweber D. Ve-ptp and ve-cadherin ectodomains interact to facilitate regulation of phosphorylation and cell contacts. EMBO J 2002; 21:4885-95; PMID:12234928; http://dx.doi.org/10.1093/emboj/cdf497
   PubMed Web of Science ®Google Scholar
• Esser S, Lampugnani MG, Corada M, Dejana E, Risau W. Vascular endothelial growth factor induces ve-cadherin tyrosine phosphorylation in endothelial cells. J Cell Sci 1998; 111(Pt 13):1853-65; PMID:9625748
   PubMed Web of Science ®Google Scholar
• Bentley K, Franco CA, Philippides A, Blanco R, Dierkes M, Gebala V, Stanchi F, Jones M, Aspalter IM, Cagna G, et al. The role of differential ve-cadherin dynamics in cell rearrangement during angiogenesis. Nat Cell Biol 2014; 16:309-21; PMID:24658686; http://dx.doi.org/10.1038/ncb2926
   PubMed Web of Science ®Google Scholar
• Broermann A, Winderlich M, Block H, Frye M, Rossaint J, Zarbock A, Cagna G, Linnepe R, Schulte D, Nottebaum AF, et al. Dissociation of ve-ptp from ve-cadherin is required for leukocyte extravasation and for vegf-induced vascular permeability in vivo. J Exp Med 2011; 208:2393-401; PMID:22025303; http://dx.doi.org/10.1084/jem.20110525
   PubMed Web of Science ®Google Scholar
• Winderlich M, Keller L, Cagna G, Broermann A, Kamenyeva O, Kiefer F, Deutsch U, Nottebaum AF, Vestweber D. Ve-ptp controls blood vessel development by balancing tie-2 activity. J Cell Biol 2009; 185:657-71; PMID:19451274; http://dx.doi.org/10.1083/jcb.200811159
   PubMed Web of Science ®Google Scholar
• De Palma M, Naldini L. Angiopoietin-2 ties up macrophages in tumor angiogenesis. Clin Cancer Res 2011; 17:5226-32; PMID:21576085; http://dx.doi.org/10.1158/1078-0432.CCR-10-0171
   PubMed Web of Science ®Google Scholar